147 related articles for article (PubMed ID: 38603656)
21. Platinum ineligibility in squamous cell carcinoma of the head and neck: consensus from Central America and the Caribbean.
Alvarado-Muñoz JF; Falco A; Morales AR; Sánchez NC; Reynoso G; Barillas A; Moreno J; López K; Prestol R; Cabreja A; Nuñez C
Future Oncol; 2021 May; 17(15):1963-1971. PubMed ID: 33559505
[TBL] [Abstract][Full Text] [Related]
22. Comparison of salvage surgery for recurrent or residual head and neck squamous cell carcinoma.
Maruo T; Zenda S; Shinozaki T; Tomioka T; Okano W; Sakuraba M; Tahara M; Hayashi R
Jpn J Clin Oncol; 2020 Mar; 50(3):288-295. PubMed ID: 31845736
[TBL] [Abstract][Full Text] [Related]
23. Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
Maihoefer C; Schüttrumpf L; Macht C; Pflugradt U; Hess J; Schneider L; Woischke C; Walch A; Baumeister P; Kirchner T; Zitzelsberger H; Belka C; Ganswindt U
Radiat Oncol; 2018 Jul; 13(1):123. PubMed ID: 29970111
[TBL] [Abstract][Full Text] [Related]
24. Salvage surgery for advanced stage head and neck squamous cell carcinoma following radiotherapy or chemoradiation.
Elbers JBW; Veldhuis LI; Bhairosing PA; Smeele LE; Jóźwiak K; van den Brekel MWM; Verheij M; Al-Mamgani A; Zuur CL
Eur Arch Otorhinolaryngol; 2019 Mar; 276(3):647-655. PubMed ID: 30673847
[TBL] [Abstract][Full Text] [Related]
25. Sonodynamic therapy and common head and neck cancers: in vitro and in vivo studies.
Hajmohammadi E; Molaei T; Mowlaei SH; Alam M; Abbasi K; Khayatan D; Rahbar M; Tebyanian H
Eur Rev Med Pharmacol Sci; 2021 Aug; 25(16):5113-5121. PubMed ID: 34486685
[TBL] [Abstract][Full Text] [Related]
26. Pediatric head and neck squamous cell carcinoma: Patient demographics, treatment trends and outcomes.
Modh A; Gayar OH; Elshaikh MA; Paulino AC; Siddiqui F
Int J Pediatr Otorhinolaryngol; 2018 Mar; 106():21-25. PubMed ID: 29447885
[TBL] [Abstract][Full Text] [Related]
27. Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma.
Xing Y; Zhang J; Lin H; Gold KA; Sturgis EM; Garden AS; Lee JJ; William WN
Cancer; 2016 Feb; 122(4):534-45. PubMed ID: 26554754
[TBL] [Abstract][Full Text] [Related]
28. Global treatment patterns and outcomes among patients with recurrent and/or metastatic head and neck squamous cell carcinoma: Results of the GLANCE H&N study.
Grünwald V; Chirovsky D; Cheung WY; Bertolini F; Ahn MJ; Yang MH; Castro G; Berrocal A; Sjoquist K; Kuyas H; Auclair V; Guillaume X; Joo S; Shah R; Harrington K;
Oral Oncol; 2020 Mar; 102():104526. PubMed ID: 31978755
[TBL] [Abstract][Full Text] [Related]
29. A nationwide study on cancer recurrences, second primary tumours, distant metastases and survival after treatment for primary head and neck cancer in the Netherlands.
van de Weerd C; van Dijk BAC; Merkx MAW; Takes RP; Brands MT
Eur J Surg Oncol; 2023 Jul; 49(7):1154-1161. PubMed ID: 36964057
[TBL] [Abstract][Full Text] [Related]
30. Single-cycle induction chemotherapy before chemoradiotherapy or surgery in functionally inoperable head and neck squamous cell carcinoma: 10-year results.
Breheret M; Lubgan D; Haderlein M; Hecht M; Traxdorf M; Schmidt D; Müller S; Kitzsteiner C; Kuwert T; Iro H; Fietkau R; Semrau S
Eur Arch Otorhinolaryngol; 2020 Jan; 277(1):245-254. PubMed ID: 31583430
[TBL] [Abstract][Full Text] [Related]
31. Outcomes Among Patients With Mucosal Head and Neck Squamous Cell Carcinoma Treated With Checkpoint Inhibitors.
Hobday SB; Brody RM; Kriegsman B; Basu D; Newman J; Cohen RB; Lukens JN; Singh A; D'Avella CA; Sun L
JAMA Otolaryngol Head Neck Surg; 2022 Oct; 148(10):918-926. PubMed ID: 35980666
[TBL] [Abstract][Full Text] [Related]
32. Patterns of recurrence after selective postoperative radiation therapy for patients with head and neck squamous cell carcinoma.
Murakami N; Matsumoto F; Yoshimoto S; Ito Y; Mori T; Ueno T; Tuchida K; Kashihara T; Kobayashi K; Harada K; Kitaguchi M; Sekii S; Umezawa R; Takahashi K; Inaba K; Igaki H; Itami J
BMC Cancer; 2016 Mar; 16():192. PubMed ID: 26951089
[TBL] [Abstract][Full Text] [Related]
33. Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy.
Sepiashvili L; Hui A; Ignatchenko V; Shi W; Su S; Xu W; Huang SH; O'Sullivan B; Waldron J; Irish JC; Perez-Ordonez B; Liu FF; Kislinger T
Mol Cell Proteomics; 2012 Nov; 11(11):1404-15. PubMed ID: 22918226
[TBL] [Abstract][Full Text] [Related]
34. Afatinib versus placebo as adjuvant therapy after chemoradiation in a double-blind, phase III study (LUX-Head & Neck 2) in patients with primary unresected, clinically intermediate-to-high-risk head and neck cancer: study protocol for a randomized controlled trial.
Burtness B; Bourhis JP; Vermorken JB; Harrington KJ; Cohen EE
Trials; 2014 Nov; 15():469. PubMed ID: 25432788
[TBL] [Abstract][Full Text] [Related]
35. Clinical decision pathway and management of locally advanced head and neck squamous cell carcinoma: A multidisciplinary consensus in Asia-Pacific.
Guo Y; Nakashima T; Cho BC; Lim DW; Yang MH; Lou PJ; Corry J; Lin JC; Zhu GP; Kim KH; Zhang B; Li Z; Hong RL; Ng JYS; Tan EM; Liu YP; Stylianou C; Spiteri C; Porceddu S
Oral Oncol; 2024 Jan; 148():106657. PubMed ID: 38101313
[TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus-associated head and neck squamous cell carcinoma survival: a comparison by tumor site and initial treatment.
Salazar CR; Smith RV; Garg MK; Haigentz M; Schiff BA; Kawachi N; Anayannis N; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF
Head Neck Pathol; 2014 Mar; 8(1):77-87. PubMed ID: 24002971
[TBL] [Abstract][Full Text] [Related]
37. Oral health and risk of squamous cell carcinoma of the head and neck and esophagus: results of two multicentric case-control studies.
Guha N; Boffetta P; Wünsch Filho V; Eluf Neto J; Shangina O; Zaridze D; Curado MP; Koifman S; Matos E; Menezes A; Szeszenia-Dabrowska N; Fernandez L; Mates D; Daudt AW; Lissowska J; Dikshit R; Brennan P
Am J Epidemiol; 2007 Nov; 166(10):1159-73. PubMed ID: 17761691
[TBL] [Abstract][Full Text] [Related]
38. External validation of the H-index (host index) in patients with head and neck squamous cell carcinomas.
Sansa A; Valero C; Holgado A; Vásquez R; Quer M; Patel SG; León X
Head Neck; 2023 Jan; 45(1):178-186. PubMed ID: 36225167
[TBL] [Abstract][Full Text] [Related]
39. Insights into metastatic roadmap of head and neck cancer squamous cell carcinoma based on clinical, histopathological and molecular profiles.
Mastronikolis NS; Delides A; Kyrodimos E; Piperigkou Z; Spyropoulou D; Giotakis E; Tsiambas E; Karamanos NK
Mol Biol Rep; 2024 Apr; 51(1):597. PubMed ID: 38683372
[TBL] [Abstract][Full Text] [Related]
40. Treatment outcomes in veterans with HPV-positive head and neck cancer.
Feinstein AJ; Shay SG; Chang E; Lewis MS; Wang MB
Am J Otolaryngol; 2017; 38(2):188-192. PubMed ID: 28342482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
